ASST
Strive, Inc.
There isn't enough reported data to score ASST yet.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
ASST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Strong |
ASST's revenue and balance sheet are currently healthy, but its profitability and cash flow are weak.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
ASST PE Valuation
ASST has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.0x next year's earnings.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
ASST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASST to return to profit, with revenue growing. However, they disagree widely on these estimates.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
ASST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.73 | — |
| Q3 2026 | -$183.86 | -$41.36 |
| Q2 2026 | -$313.10 | -$286.40 |
| Q1 2026 | -$312.73 | -$277.83 |
| Q4 2025 | -$310.80 | -$242.50 |
| Q3 2025 | -$142.50 | -$78.70 |
| Q2 2025 | -$26.70 | +$37.90 |
| Q1 2025 | -$34.90 | +$28.10 |
| Q4 2024 | -$68.30 | -$32.30 |
ASST lost $183.86 per share over the past year, a bigger loss than the year before.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over ASST in the latest year-over-year earnings comparison.
ASST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +75% |
| Q2 2026 | $2.9M | +1597% |
| Q1 2026 | $2.8M | +1516% |
| Q4 2025 | $1.5M | +611% |
| Q3 2025 | $1.5M | +660% |
| Q2 2025 | $173.3K | +86% |
| Q1 2025 | $170.7K | +37% |
| Q4 2024 | $212.8K | +163% |
ASST has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18844% | +20355 points |
| Q2 2026 | -8781% | -7227 points |
| Q1 2026 | -11346% | -10376 points |
| Q4 2025 | -15948% | -15020 points |
| Q3 2025 | -1511% | -863 points |
| Q2 2025 | -1554% | +303 points |
| Q1 2025 | -970% | +141 points |
| Q4 2024 | -928% | +739 points |
ASST's operating margin was 18844% last quarter, up 20355 points from the same quarter a year ago, near the top of its range since 2021.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
ASST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.1M | +$18.8M |
| Q3 2025 | -$28.9M | -$27.8M |
| Q2 2024 | -$1.3M | -$146.2K |
| Q1 2024 | -$1.1M | -$224.6K |
| Q4 2023 | -$860.1K | -$650.5K |
| Q2 2023 | -$1.1M | -$917.5K |
| Q1 2023 | -$829.9K | -$754.9K |
| Q4 2022 | -$209.6K | -5434% |
ASST has burned cash in almost every quarter: −$75M over the past year, against −$32M the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
ASST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +15.3M shares |
| 1 year | +5331% | +88.9M shares |
| 3 years | +65691% | +90.4M shares |
| 5 years | +1478019% | +90.5M shares |
ASST has 91M diluted shares, up 5331% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | $500,000 |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over ASST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
ASST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -1.7x | Net Cash |
ASST has more cash than debt.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
ASST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 51.4 | Neutral |
ASST's weekly RSI is 51 (neutral) and its Stochastic is 51 (neutral).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
ASST PE vs Communication Services Sector
ASST has no meaningful PE right now: it lost money over the past year.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
ASST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.8 | 14% below |
| 20 week MA | $20.8 | 7% above |
| 50 week MA | $16.8 | 32% above |
| 100 week MA | $35.7 | 38% below |
ASST has stronger trend alignment. ASST is above 2 of 4 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
ASST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $355.0 | $63.9 | -82% |
| 2024 | $63.9 | $9.32 | -85% |
| 2025 | $9.32 | $16.3 | +75% |
| 2026 YTD | $16.3 | $22.3 | +37% |
ASST is up 37% so far in 2026, after finishing lower in two of the previous three years.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over ASST on returns for 2026, with the stronger performance.